{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T22:33:10Z","timestamp":1726007590327},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2008,7,5]],"date-time":"2008-07-05T00:00:00Z","timestamp":1215216000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s00417-008-0873-9","type":"journal-article","created":{"date-parts":[[2008,7,4]],"date-time":"2008-07-04T11:17:38Z","timestamp":1215170258000},"page":"1603-1608","source":"Crossref","is-referenced-by-count":8,"title":["Soluble endothelial protein C receptor levels in Beh\u00e7et patients with and without ocular involvement"],"prefix":"10.1007","volume":"246","author":[{"given":"F. Nil\u00fcfer","family":"Yal\u00e7\u0131nda\u011f","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Figen","family":"Bat\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6zden","family":"\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esra","family":"Cans\u0131zo\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonca","family":"E\u011fin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nejat","family":"Akar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,7,5]]},"reference":[{"key":"873_CR1","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1055\/s-0037-1613358","volume":"88","author":"N Akar","year":"2002","unstructured":"Akar N, Gokdemir R, Ozel D, Akar E (2002) Endothelial cell protein C receptor (EPCR) gene exon III, 23-bp insertion mutation in the Turkish pediatric thrombotic patients. Thromb Haemost 88:1068\u20131069","journal-title":"Thromb Haemost"},{"key":"873_CR2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000077824","volume":"33","author":"A Ates","year":"2003","unstructured":"Ates A, Duzgun N, Ulu A, Tiryaki AO, Akar N (2003) Factor V gene (1691A and 4070G) and prothrombin gene 20210A mutations in patients with Behcet\u2019s disease. Pathophysiol Haemost Thromb 33:157\u2013163 doi: 10.1159\/000077824","journal-title":"Pathophysiol Haemost Thromb"},{"key":"873_CR3","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1034\/j.1600-0420.2003.00068.x","volume":"81","author":"F Batioglu","year":"2003","unstructured":"Batioglu F, Atmaca LS, Karabulut HG, Say\u0131n DB (2003) Factor V Leiden and prothrombin gene G20210A mutations in ocular Beh\u00e7et disease. Acta Ophthalmol Scand 81:283\u2013285 doi: 10.1034\/j.1600-0420.2003.00068.x","journal-title":"Acta Ophthalmol Scand"},{"key":"873_CR4","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1055\/s-0037-1616515","volume":"86","author":"E Biguzzi","year":"2001","unstructured":"Biguzzi E, Merati G, Liaw PC, Bucciarelli P, Oganesyan N, Qu D, Gu JM, Fetiveau R, Esmon CT, Mannucci PM, Faioni EM (2001) A 23-bp insertion in the endothelial protein C receptor (EPCR) gene impairs EPCR function. Thromb Haemost 86:945\u2013948","journal-title":"Thromb Haemost"},{"key":"873_CR5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1365-2249.2002.01803.x","volume":"128","author":"MM Boomsma","year":"2002","unstructured":"Boomsma MM, Stearns-Kurosawa DJ, Stegeman CA, Raschi E, Meroni PL, Kurosawa S, Tervaert JW (2002) Plasma levels of soluble endothelial cell protein C receptor in patients with Wegener\u2019s granulomatosis. Clin Exp Immunol 128:187\u2013194 doi: 10.1046\/j.1365-2249.2002.01803.x","journal-title":"Clin Exp Immunol"},{"key":"873_CR6","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0735-1097(00)01137-2","volume":"37","author":"JC Chambers","year":"2001","unstructured":"Chambers JC, Haskar DO, Kooner JS (2001) Vascular endothelial function and oxidative stress mechanism in patients with Beh\u00e7et\u2019s syndrome. J Am Coll Cardiol 37:517\u2013520 doi: 10.1016\/S0735-1097(00)01137-2","journal-title":"J Am Coll Cardiol"},{"key":"873_CR7","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1128\/MCB.8.12.5588","volume":"8","author":"EM Conway","year":"1988","unstructured":"Conway EM, Rosenberg RD (1988) Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Mol Cell Biol 8:5588\u20135592","journal-title":"Mol Cell Biol"},{"key":"873_CR8","first-page":"363","volume":"84","author":"CT Esmon","year":"1999","unstructured":"Esmon CT, Gu J, Xu J, Qu D, Stearns-Kurosawa DJ, Kurosawa S (1999) Regulation and functions of the protein C anticoagulant pathway. Haematologica 84:363\u2013368","journal-title":"Haematologica"},{"key":"873_CR9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1378\/chest.124.3_suppl.26S","volume":"124","author":"CT Esmon","year":"2003","unstructured":"Esmon CT (2003) The protein C pathway. Chest 124:26\u201332 doi: 10.1378\/chest.124.3_suppl.26S","journal-title":"Chest"},{"key":"873_CR10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.maturitas.2003.10.015","volume":"47","author":"CT Esmon","year":"2004","unstructured":"Esmon CT (2004) Crosstalk between inflammation and thrombosis. Maturitas 47:305\u2013314 doi: 10.1016\/j.maturitas.2003.10.015","journal-title":"Maturitas"},{"key":"873_CR11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/01.CCM.0000126128.64614.81","volume":"32","author":"CT Esmon","year":"2004","unstructured":"Esmon CT (2004) Structure and functions of the endothelial cell protein C receptor. Crit Care Med 32:298\u2013301 doi: 10.1097\/01.CCM.0000126128.64614.81","journal-title":"Crit Care Med"},{"key":"873_CR12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1042\/BST0330401","volume":"33","author":"CT Esmon","year":"2005","unstructured":"Esmon CT (2005) Coagulation inhibitors in inflammation. Biochem Soc Trans 33:401\u2013405 doi: 10.1042\/BST0330401","journal-title":"Biochem Soc Trans"},{"key":"873_CR13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0002-9343(01)01048-8","volume":"112","author":"G Espinosa","year":"2002","unstructured":"Espinosa G, Font J, Tassies D, Vidaller A, Deulofeu R, Lopez-Soto A, Cervera R, Ordinas A, Ingelmo M, Reverter J (2002) Vascular involvement in Beh\u00e7et\u2019s disease: Relation with thrombophilic factors, coagulation activation, and thrombomodulin. Am J Med 112:37\u201343 doi: 10.1016\/S0002-9343(01)01048-8","journal-title":"Am J Med"},{"key":"873_CR14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/01.CCM.0000128032.85396.83","volume":"32","author":"EM Faioni","year":"2004","unstructured":"Faioni EM, Ferrero S, Fontana G, Gianelli U, Ciulla MM, Vecchi M, Saibeni S, Biguzzi E, Cordani N, Franchi F, Bosari S, Cattaneo M (2004) Expression of endothelial protein C receptor and thrombomodulin in the intestinal tissue of patients with inflammatory bowel disease. Crit Care Med 32:266\u2013270 doi: 10.1097\/01.CCM.0000128032.85396.83","journal-title":"Crit Care Med"},{"key":"873_CR15","doi-asserted-by":"crossref","first-page":"26486","DOI":"10.1016\/S0021-9258(18)47220-1","volume":"269","author":"K Fukudome","year":"1994","unstructured":"Fukudome K, Esmon CT (1994) Identification, cloning, and regulation of a novel endothelial cell protein C\/activated protein C receptor. J Biol Chem 269:26486\u201326491","journal-title":"J Biol Chem"},{"key":"873_CR16","doi-asserted-by":"crossref","first-page":"17491","DOI":"10.1074\/jbc.271.29.17491","volume":"271","author":"K Fukudome","year":"1996","unstructured":"Fukudome K, Kurosawa S, Stearns-Kurosawa DJ, He X, Rezaie AR, Esmon CT (1996) The endothelial cell protein C receptor. Cell surface expression and direct ligand binding by the soluble receptor. J Biol Chem 271:17491\u201317498 doi: 10.1074\/jbc.271.29.17491","journal-title":"J Biol Chem"},{"key":"873_CR17","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1046\/j.1365-2141.2001.03187.x","volume":"115","author":"L Galligan","year":"2001","unstructured":"Galligan L, Livingstone W, Volkov Y, Hokamp K, Murphy C, Lawler M, Fukudome K, Smith O (2001) Characterization of protein C receptor expression in monocytes. Br J Haematol 115:408\u2013414 doi: 10.1046\/j.1365-2141.2001.03187.x","journal-title":"Br J Haematol"},{"key":"873_CR18","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.4049\/jimmunol.153.8.3664","volume":"153","author":"ST Grey","year":"1994","unstructured":"Grey ST, Tsuchida A, Hau H, Orthner CL, Salem HH, Hancock WW (1994) Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-\u03b3 or phorbol ester. J Immunol 153:3664\u20133672","journal-title":"J Immunol"},{"key":"873_CR19","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/rheumatology\/35.11.1178","volume":"35","author":"A Gul","year":"1996","unstructured":"Gul A, Ozbek U, Ozturk C, Inanc M, Koni\u00e7e M, Oz\u00e7elik T (1996) Coagulation factor V gene mutation increases the risk of venous thrombosis in Beh\u00e7et\u2019s disease. Br J Rheumatol 35:1178\u20131180 doi: 10.1093\/rheumatology\/35.11.1178","journal-title":"Br J Rheumatol"},{"key":"873_CR20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1442-9071.2006.01212.x","volume":"34","author":"K Gumus","year":"2006","unstructured":"Gumus K, Kadayifcilar S, Eldem B, Saracbasi O, Ozcebe O, Dundar S, Kirazli S (2006) Is elevated level of soluble endothelial protein C receptor a new risk factor for retinal vein occlusion. Clin Experiment Ophthalmol 34:305\u2013311 doi: 10.1111\/j.1442-9071.2006.01212.x","journal-title":"Clin Experiment Ophthalmol"},{"key":"873_CR21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1600-0609.1996.tb00499.x","volume":"57","author":"IC Haznedaroglu","year":"1996","unstructured":"Haznedaroglu IC, Ozcebe O, \u00c7elik I, D\u00fcndar SV, Kirazli S (1996) Haemostatic markers of procoagulant imbalance in Beh\u00e7et\u2019s disease. Eur J Haematol 57:107\u2013108","journal-title":"Eur J Haematol"},{"key":"873_CR22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0049-3848(02)00006-3","volume":"105","author":"S Kiraz","year":"1994","unstructured":"Kiraz S, Ertenli I, Ozturk MA, Haznedaroglu IC, Celik I, Calguneri M (1994) Pathological haemostasis and \u2018prothrombotic state\u2019 in Beh\u00e7et\u2019s disease. Thromb Res 105:125\u2013133 doi: 10.1016\/S0049-3848(02)00006-3","journal-title":"Thromb Res"},{"key":"873_CR23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s002960050043","volume":"17","author":"A Kosar","year":"1998","unstructured":"Kosar A, Haznedaroglu IC, Buyukas\u0131k Y, Kirazli S, Dundar SV (1998) Activated protein C resistance in Beh\u00e7et\u2019s disease. Rheumatol Int 17:249\u2013250 doi: 10.1007\/s002960050043","journal-title":"Rheumatol Int"},{"key":"873_CR24","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1172\/JCI119548","volume":"100","author":"S Kurosawa","year":"1997","unstructured":"Kurosawa S, Stearns-Kurosawa DJ, Hidari N, Esmon CT (1997) Identification of functional endothelial protein C receptor in human plasma. J Clin Invest 100:411\u2013418 doi: 10.1172\/JCI119548","journal-title":"J Clin Invest"},{"key":"873_CR25","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1182\/blood.V91.2.725","volume":"91","author":"S Kurosawa","year":"1998","unstructured":"Kurosawa S, Stearns-Kurosawa DJ, Carson CW, D\u2019Angelo A, Della Valle P, Esmon CT (1998) Plasma levels of endothelial cell protein C receptor are elevated in patients with sepsis and systemic lupus erythematosus: lack of correlation with thrombomodulin suggests involvement of different pathological processes. Blood 91:725\u2013727","journal-title":"Blood"},{"key":"873_CR26","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1161\/01.CIR.96.10.3633","volume":"96","author":"Z Laszik","year":"1997","unstructured":"Laszik Z, Mitro A, Taylor FB Jr, Ferrell G, Esmon CT (1997) Human protein C receptor is present primarily on endothelium of large blood vessels: implications for the control of the protein C pathway. Circulation 96:3633\u20133640","journal-title":"Circulation"},{"key":"873_CR27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0049-3848(02)00085-3","volume":"106","author":"YJ Lee","year":"1994","unstructured":"Lee YJ, Kang SW, Yang JI, Choi YM, Sheen D, Lee EB, Choi SW, Song YW (1994) Coagulation parameters and plasma total homocysteine levels in Behcet\u2019s disease. Thromb Res 106:19\u201324 doi: 10.1016\/S0049-3848(02)00085-3","journal-title":"Thromb Res"},{"key":"873_CR28","doi-asserted-by":"crossref","first-page":"5447","DOI":"10.1074\/jbc.275.8.5447","volume":"275","author":"PCY Liaw","year":"2000","unstructured":"Liaw PCY, Neuenschwander PF, Smirnov MD, Esmon CT (2000) Mechanisms by which soluble endothelial cell protein C receptor modulates protein C and activated protein C function. J Biol Chem 275:5447\u20135452 doi: 10.1074\/jbc.275.8.5447","journal-title":"J Biol Chem"},{"key":"873_CR29","first-page":"341","volume":"19","author":"JT Lie","year":"1992","unstructured":"Lie JT (1992) Vascular involvement in Beh\u00e7et\u2019s disease: arterial and venous and vessels of all sizes. J Rheumatol 19:341\u2013343","journal-title":"J Rheumatol"},{"key":"873_CR30","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1182\/blood.V87.2.642.bloodjournal872642","volume":"87","author":"K Murakami","year":"1996","unstructured":"Murakami K, Okajima K, Uchiba M, Johno M, Nakagaki T, Okabe H, Takatsuki K (1996) Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats. Blood 87:642\u2013647","journal-title":"Blood"},{"key":"873_CR31","first-page":"197","volume":"272","author":"K Murakami","year":"1997","unstructured":"Murakami K, Okajima K, Uchiba M, Johno M, Nakagaki T, Okabe H, Takatsuki K (1997) Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production. Am J Physiol 272:197\u2013202","journal-title":"Am J Physiol"},{"key":"873_CR32","unstructured":"Murphy C, Livingstone WJ, White B (2001) Activated protein C inhibits upregulation of both tissue factor and TNF-\u03b1 in endotoxin stimulated monocytes. Thromb Haemost Suppl: 509"},{"key":"873_CR33","first-page":"496","volume":"25","author":"AF Oner","year":"1998","unstructured":"Oner AF, Gurgey A, Gurler A, Mesci L (1998) Factor V Leiden mutation in patients with Beh\u00e7et\u2019s disease. J Rheumatol 25:496\u2013498","journal-title":"J Rheumatol"},{"key":"873_CR34","doi-asserted-by":"crossref","first-page":"26279","DOI":"10.1074\/jbc.272.42.26279","volume":"272","author":"LM Regan","year":"1997","unstructured":"Regan LM, Mollica JS, Rezaie AR, Esmon CT (1997) The interaction between the endothelial cell protein C receptor and protein C is dictated by the gamma-carboxyglutamic acid domain of protein C. J Biol Chem 272:26279\u201326284 doi: 10.1074\/jbc.272.42.26279","journal-title":"J Biol Chem"},{"key":"873_CR35","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF02912462","volume":"27","author":"R Rizzi","year":"1997","unstructured":"Rizzi R, Bruno S, Dammacco R (1997) Beh\u00e7et\u2019s disease: an immune-mediated vasculitis involving vessels of all sizes. Int J Clin Lab Res 27:225\u2013232 doi: 10.1007\/s005990050002","journal-title":"Int J Clin Lab Res"},{"key":"873_CR36","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"341","author":"T Sakane","year":"1999","unstructured":"Sakane T, Takeno M, Suzuki N, Inaba G (1999) Beh\u00e7et\u2019s disease. N Eng J Med 341:1284\u20131291 doi: 10.1056\/NEJM199910213411707","journal-title":"N Eng J Med"},{"key":"873_CR37","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1182\/blood-2003-07-2520","volume":"103","author":"B Saposnik","year":"2004","unstructured":"Saposnik B, Reny JL, Gaussem P, Emmerich J, Aiach M, Gandrille S (2004) EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis. Blood 103:1311\u20131318 doi: 10.1182\/blood-2003-07-2520","journal-title":"Blood"},{"key":"873_CR38","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.thromres.2005.04.029","volume":"117","author":"P Simioni","year":"2006","unstructured":"Simioni P, Morboeuf O, Tognin G, Gavasso S, Tormene D, Woodhams B, Pagnan A (2006) Soluble endothelial cell protein C receptor (sEPCR) levels and venous thromboembolism in carriers of two dysfunctional protein C variants. Thromb Res 117:523\u2013528 doi: 10.1016\/j.thromres.2005.04.029","journal-title":"Thromb Res"},{"key":"873_CR39","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1055\/s-0037-1616513","volume":"86","author":"RE Simmonds","year":"2001","unstructured":"Simmonds RE, Lane DA (2001) The endothelial cell protein C receptor: a candidate genetic risk factor for thrombosis. Thromb Haemost 86:939\u2013941","journal-title":"Thromb Haemost"},{"key":"873_CR40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/107602960601200108","volume":"12","author":"T Sipahi","year":"2006","unstructured":"Sipahi T, Pocan H, Akar N (2006) Effects of various genetic polymorphisms on the incidence and outcome of severe sepsis. Clin Appl Thrombosis\/Hemostasis 12:47\u201354 doi: 10.1177\/107602960601200108","journal-title":"Clin Appl Thrombosis\/Hemostasis"},{"key":"873_CR41","doi-asserted-by":"crossref","first-page":"10212","DOI":"10.1073\/pnas.93.19.10212","volume":"93","author":"DJ Stearns-Kurosawa","year":"1996","unstructured":"Stearns-Kurosawa DJ, Kurosawa S, Mollica JS, Ferrell GL, Esmon CT (1996) The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. Proc Natl Acad Sci USA 93:10212\u201310216 doi: 10.1073\/pnas.93.19.10212","journal-title":"Proc Natl Acad Sci U S A"},{"key":"873_CR42","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1182\/blood.V99.2.526","volume":"99","author":"DJ Stearns-Kurosawa","year":"2002","unstructured":"Stearns-Kurosawa DJ, Swindle K, D\u2019Angelo A, Della Valle P, Fattorini A, Caron N, Grimaux M, Woodhams B, Kurosawa S (2002) Plasma levels of endothelial protein C receptor respond to anticoagulant treatment. Blood 99:526\u2013530 doi: 10.1182\/blood.V99.2.526","journal-title":"Blood"},{"key":"873_CR43","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2002-12-3880","volume":"102","author":"DH Sturn","year":"2003","unstructured":"Sturn DH, Kaneider NC, Feistritzer C, Djanani A, Fukudome K, Wiedermann CJ (2003) Expression and function of the endothelial protein C receptor in human neutrophils. Blood 102:1499\u20131505 doi: 10.1182\/blood-2002-12-3880","journal-title":"Blood"},{"key":"873_CR44","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1182\/blood.V95.5.1680.005k33_1680_1686","volume":"95","author":"FB Taylor Jr","year":"2000","unstructured":"Taylor FB Jr, Stearns-Kurosawa DJ, Kurosawa S, Ferrell G, Chang AC, Laszik Z, Kosanke S, Peer G, Esmon CT (2000) The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis. Blood 95:1680\u20131686","journal-title":"Blood"},{"key":"873_CR45","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1182\/blood.V97.6.1685","volume":"97","author":"FB Taylor Jr","year":"2001","unstructured":"Taylor FB Jr, Peer GT, Lockhart MS, Ferrell G, Esmon CT (2001) Endothelial cell protein C receptor plays an important role in protein C activation in vivo. Blood 97:1685\u20131688 doi: 10.1182\/blood.V97.6.1685","journal-title":"Blood"},{"key":"873_CR46","first-page":"2849","volume":"27","author":"PB Toydemir","year":"2000","unstructured":"Toydemir PB, Elhan AH, T\u00fck\u00fcn A, Toydemir R, G\u00fcrler A, T\u00fcz\u00fcner A, Bokesoy I (2000) Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothrombin gene G20210A mutations on deep venous thrombosis in Beh\u00e7et\u2019s disease. J Rheumatol 27:2849\u20132854","journal-title":"J Rheumatol"},{"key":"873_CR47","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1046\/j.1538-7836.2004.00855.x","volume":"2","author":"S Uitte D Willige","year":"2004","unstructured":"Uitte D Willige S, Van Marion V, Rosendaal FR, Vos HL, De Visser MCH, Bertina RM (2004) Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis. J Thromb Haemost 2:1305\u20131310 doi: 10.1046\/j.1538-7836.2004.00855.x","journal-title":"J Thromb Haemost"},{"key":"873_CR48","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.thromres.2006.08.004","volume":"120","author":"A Ulu","year":"2007","unstructured":"Ulu A, Gunal D, Tiras S, Egin Y, Deda G, Akar N (2007) EPCR gene A3 haplotype and elevated soluble endothelial protein C receptor (sEPCR) levels in Turkish pediatric stroke patients. Thromb Res 120:47\u201352 doi: 10.1016\/j.thromres.2006.08.004","journal-title":"Thromb Res"},{"key":"873_CR49","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0002-9394(99)00184-1","volume":"128","author":"DH Verity","year":"1999","unstructured":"Verity DH, Vaughan RW, Madanat W, Kondeatis E, Zureikat H, Fayyad F, Kanawati CA, Ayesh I, Stanford MR, Wallace GR (1999) Factor V Leiden mutation is associated with ocular involvement in Beh\u00e7et\u2019s disease. Am J Ophthalmol 128:352\u2013356 doi: 10.1016\/S0002-9394(99)00184-1","journal-title":"Am J Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-008-0873-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-008-0873-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-008-0873-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T02:44:23Z","timestamp":1684464263000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-008-0873-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,5]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["873"],"URL":"https:\/\/doi.org\/10.1007\/s00417-008-0873-9","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,5]]}}}